Welcome to a new era of sustainable weight loss and healthier living
KARE Lifestyle transforms weight-loss and wellness care through an innovative digital platform providing affordable, accessible “lifestyle medications.” By delivering personalized care, including access to GLP-1 medications, we empower individuals to achieve sustainable weight management and help address diverse lifestyle medical needs.
503A Pharmacies
Strategic partnership and LOI for full acquisition of multiple 503A pharmacies for enhanced supply chain management, access to diverse patient populations, real-time data, and increased visibility and collaboration.
503B Pharmacies
Partnership is currently building out a 503B facility to produce large quantities to lower manufacturing costs and ensure a consistent supply of essential medications and alleviate drug shortages.
Expanding Access and Driving Demand
Chuck Jenkins
Chuck is a seasoned healthcare executive with 25 years of experience in launching and commercializing pharmaceutical products, devices, and companies. Prior to his current role at KARE Health Partners, he served as EVP of Business Development at Genefic Inc., a San Diego-based healthcare holdings company with diversified operations, including specialty and infusion pharmacies and a full-service diagnostic lab.
A proven leader in dermatology, Chuck played a pivotal role at Medicis Pharmaceuticals, where he successfully launched and managed SOLODYN, the #1 prescribed drug in the field, generating $780 million in annual revenue and positioning Medicis as a top publicly traded dermatology company. He later co-founded Innocutis Pharmaceuticals, a private equity-backed company, leading it as Chief Commercial Officer to a successful acquisition by Cipher Pharmaceuticals within four years.
Following this exit, Chuck spearheaded multiple ventures in the Life Sciences and Healthcare Services sectors. His leadership approach emphasizes integrity, alignment with senior management objectives, pragmatic strategies, and team empowerment.